Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Nov;65(11):4843-9.
doi: 10.1128/iai.65.11.4843-4849.1997.

Lethal tuberculosis in interleukin-6-deficient mutant mice

Affiliations

Lethal tuberculosis in interleukin-6-deficient mutant mice

C H Ladel et al. Infect Immun. 1997 Nov.

Abstract

Tuberculosis is a chronic infectious disease which causes major health problems globally. Acquired resistance is mediated by T lymphocytes and executed by activated macrophages. In vitro studies have emphasized the importance of macrophage activation for mycobacterial growth inhibition. In vivo, the protective host response is focused on granulomatous lesions in which Mycobacterium tuberculosis is contained. A cellular immune response of the T helper 1 (Th1) type is considered central for control of tuberculosis. Using interleukin-6 (IL-6)-deficient mice, we here demonstrate a crucial role of this pluripotent cytokine in protection against M. tuberculosis but not against Mycobacterium bovis BCG. Infection with M. tuberculosis was lethal for the IL-6-deficient mice at inocula that were still controlled by IL-6-competent mice. Spleen cells from M. tuberculosis-infected IL-6-/- mouse mutants produced elevated levels of IL-4 and reduced levels of gamma interferon compared to the control levels. Cytofluorometric analyses of spleen cells from M. tuberculosis-infected mice revealed more-profound alterations in T-cell ratios in IL-6-/- mice than in control mice. We assume that IL-6 contributes to host resistance by its proinflammatory activity and by its influence on cytokine secretion.

PubMed Disclaimer

References

    1. Annu Rev Immunol. 1990;8:253-78 - PubMed
    1. Infect Immun. 1990 Jan;58(1):269-71 - PubMed
    1. J Leukoc Biol. 1992 Mar;51(3):225-9 - PubMed
    1. Immunol Rev. 1992 Jun;127:25-50 - PubMed
    1. Science. 1992 Aug 21;257(5073):1055-64 - PubMed

Publication types